Tianming Pharma: Powering the Oral GLP-1 Revolution with Orforglipron Intermediates
Tianming Pharma pioneers Orforglipron intermediates for oral GLP-1 drugs, enabling cold chain-free obesity/diabetes therapies. Backed by China’s policy & scaled cGMP production, we power global partners to reshape markets with innovation.